Skip to main content

Table 1 Schedule of Procedures

From: Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial

Procedure Entry (D0) Daily 1–5 (on treatment) Day 6 Final Visit (Day 7)
Consent    
Age    
Gender    
Electrolytes    
Liver function    
MMSE
Digit Span
CAM
MDAS
Motor type    
CMI    
IQCODE a    
GDS-15    
Katz ADL    
Presence of Restraints  
# Falls  
# Pressure areas b
Rescue medication  
Adverse events   
Review INR c c   
  1. aIdeally the IQCODE will be measured at entry but can be measured at any point
  2. bInitial number and location will be recorded at entry in order to derive the number of new areas at each subsequent visit
  3. cIf participant is on warfarin, we will review the INR that has been performed every 1–2 days as is standard protocol for acutely unwell inpatients when warfarinised